Methotrexate - METHOTREXATE SODIUM
Navigation: NDC > Supplier starting with: H > HOSPIRA WORLDWIDE, INC.| Field | Value |
|---|---|
| NDC Code: | 61703-411 |
| Proprietary Name: | Methotrexate |
| Suffix: | |
| Non-Proprietary Name: | METHOTREXATE SODIUM |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Original Marketing Date: | 02-03-2012 |
| End of Marketing: | 31-01-2014 |
| Category Name: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Application Number: | |
| Labeler: | HOSPIRA WORLDWIDE, INC. |
| Substance Name: | METHOTREXATE SODIUM |
| Active Numerator Strength: | 25 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| DEA Schedule: |